SEARCH

SEARCH BY CITATION

The associate editors of Headache, individuals who play a pivotal role in advising the editor-in-chief on the publication worthiness of a submission, are committed to ensuring that the journal's review process is transparent. In support of that objective, Headache will publish an annual declaration of all conflicts of interest for members of the board for the previous 12 months. Headache aims to be compliant with the International Committee of Medical Journal Editors (ICMJE) statement encouraging all journals to publish any potential conflicts within the editorial review process.

From the ICMJE Uniform Requirements:

II.D.3. Potential Conflicts of Interest Related to Commitments of Editors, Journal Staff, or Reviewers

“Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and disqualify themselves from any decisions where they have a conflict of interest. Editorial staff must not use the information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff.”

The Headache associate editors were requested to provide their conflicts of interest during the past year using the standard American Headache Society disclosure form.

Editor-in-Chief

Thomas N. Ward, MD

No conflicts of interest

Associate Editors

Andrew Ahn, MD, PhD

No conflicts of interest

Sheena Aurora, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan, Eneura, Merck

    Relationship level: Significant level relationship – (more than $10,000)

  2. Relationship category: Research grants

    Name of commercial interest: Lilly, Allergan, Merck

    Relationship level: Significant level relationship – (more than $10,000)

Rebecca Burch, MD

No conflicts of interest

Roger Cady, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Meda Pharmaceuticals, Novartis, NuPathe, Ortho-McNeil Neurologics

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan, Astellas, GlaxoSmithKline, MAP, Merck, Nautilus Neuroscience, Zogenix

    Relationship level: Significant level relationship – (more than $10,000)

  3. Relationship category: Speaker's Bureau

    Name of commercial interest: Nautilus Neuroscience, Novartis

    Relationship level: Modest level relationship – (less than $10,000)

  4. Relationship category: Speaker's Bureau

    Name of commercial interest: Allergan, Astellas, Merck, Zogenix

    Relationship level: Significant level relationship – (more than $10,000)

  5. Relationship category: Research grants

    Name of commercial interest: Advanced Neuromodulation, Allergan, AstraZeneca, Boston Scientific, Endo Pharmaceutics, GlaxoSmithKline, Johnson and Johnson, MAP Pharmaceuticals, Merck, PuraMed BioScience, Wyeth, Zogenix (all directed to Dr. Cady's institution)

    Relationship level: Significant level relationship – (more than $10,000)

Deborah Friedman, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Neurology Reviews, MedLink Neurology, MAP

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Research grants

    Name of commercial interest: Merck, National Eye Institutes (all directed to Dr. Friedman's institution)

    Relationship level: Significant level relationship – (more than $10,000)

  3. Relationship category: Speaker's Bureau

    Name of commercial interest: Allergan

    Relationship level: Significant level relationship – (more than $10,000)

  4. Relationship category: Expert witness testimony and other financial benefit

    Details: Expert witness for both plaintiff and defense in cases of PTCS

    Relationship level: Modest level relationship – (less than $10,000)

Lyn Griffiths, PhD

No conflicts of interest

Andrew Hershey, MD, PhD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan

    Relationship level: Modest level relationship – (less than $10,000)

Robert Kaniecki, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Zogenix

    Relationship level: Modest level relationship – (less than $10,000)

Abouch Krymchantowski, MD, PhD

No conflicts of interest

Elizabeth Loder, MD

Relationship category: Salary

Name of commercial interest: British Medical Journal – for services as an editor (paid to institution)

Relationship level: Significant level relationship – (more than $10,000)

Vincent Martin, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: MAPP, Allergen, Nautilus, Zogenix, NuPathe

    Relationship level: Significant level relationship – (more than $10,000)

  2. Relationship category: Research grants

    Name of commercial interest: GSK

    Relationship level: Significant level relationship – (more than $10,000)

  3. Relationship category: Speaker's Bureau

    Name of commercial interest: Zogenix, Allergan, Nautilus

    Relationship level: Significant level relationship – (more than $10,000)

Brian E. McGeeney, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Merck, Allergan, MAP

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Equity interests

    Name of commercial interest: Pfizer

    Relationship level: Modest level relationship – (less than $10,000)

  3. Relationship category: Officer, director, or other fiduciary role

    Details: Headache Cooperative of New England

Julio Pascual, MD, PhD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: MSD, Allergan, Almirall

    Relationship level: Modest level relationship – (less than $10,000)

Donald B. Penzien, PhD

  1. Relationship category: Research grants

    Name of commercial interest: Merck

    Relationship level: Significant level relationship – (more than $10,000)

B. Lee Peterlin, DO

  1. Relationship category: Royalty income

    Name of commercial interest: Oxford University Press

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Research grants from a financial interested company

    Name of commercial interest: GSK, Luitpold Pharmaceuticals

    Relationship level: Significant level relationship – (more than $10,000)

Luiz P. Queiroz, MD

No conflicts of interest

Jeanetta Rains, PhD

No conflicts of interest

Paul B. Rizzoli, MD

No conflicts of interest

Todd J. Schwedt, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan, Zogenix

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Research grants

    Name of commercial interest: Merck

    Relationship level: Modest level relationship – (less than $10,000)

Todd A. Smitherman, PhD

  1. Relationship category: Research grants

    Name of commercial interest: Merck

    Relationship level: Modest level relationship – (less than $10,000)

Deborah E. Tepper, MD

Please refer to the disclosure for Stewart J. Tepper (as spouse)

Stewart J. Tepper, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan, ATI, Impax, Merck, Nautilus, NuPathe, Pfizer, Zogenix

    Relationship level: Significant level relationship – (more than $10,000)

  2. Relationship category: Speaker's Bureau

    Name of commercial interest: Allergan, Impax, MAP, Nautilus, Zogenix

    Relationship level: Significant level relationship – (more than $10,000)

  3. Relationship category: Equity interests/Stock options

    Name of commercial interest: ATI

    Relationship level: Modest level relationship – (less than $10,000)

  4. Relationship category: Royalty income

    Name of commercial interest: University of Mississippi Press, Peoples Publishing House of Peking, Springer

    Relationship level: Modest level relationship – (less than $10,000)

Gretchen E. Tietjen, MD

No conflicts of interest

Marcelo M. Valença, MD, PhD

No conflicts of interest

Shuu-Jiun Wang, MD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan, Eli Lilly (Taiwan), Pfizer

    Relationship level: Modest level relationship – (less than $10,000)

  2. Relationship category: Speaker's Bureau

    Name of commercial interest: Allergan, Boehringer Ingelheim (Taiwan), Eli Lilly (Taiwan), GSK (Taiwan), Pfizer (Taiwan)

    Relationship level: Modest level relationship – (less than $10,000)

Randall E. Weeks, PhD

  1. Relationship category: Consulting fees/Honoraria

    Name of commercial interest: Allergan

    Relationship level: Modest level relationship – (less than $10,000)